645 related articles for article (PubMed ID: 19358302)
21. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
[TBL] [Abstract][Full Text] [Related]
22. Direct medical costs of bronchiolitis hospitalizations in the United States.
Pelletier AJ; Mansbach JM; Camargo CA
Pediatrics; 2006 Dec; 118(6):2418-23. PubMed ID: 17142527
[TBL] [Abstract][Full Text] [Related]
23. Examining the effectiveness of hydroxyurea in people with sickle cell disease.
Lanzkron S; Haywood C; Fagan PJ; Rand CS
J Health Care Poor Underserved; 2010 Feb; 21(1):277-86. PubMed ID: 20173269
[TBL] [Abstract][Full Text] [Related]
24. Resource utilization and costs of treating severe rotavirus diarrhea in young Mexican children from the health care provider perspective.
Granados-García V; Velázquez-Castillo R; Garduño-Espinosa J; Torres-López J; Muñoz-Hernández O
Rev Invest Clin; 2009; 61(1):18-25. PubMed ID: 19507471
[TBL] [Abstract][Full Text] [Related]
25. Ambulatory care connections of Medicaid-insured children with sickle cell disease.
Bundy DG; Muschelli J; Clemens GD; Strouse JJ; Thompson RE; Casella JF; Miller MR
Pediatr Blood Cancer; 2012 Nov; 59(5):888-94. PubMed ID: 22422739
[TBL] [Abstract][Full Text] [Related]
26. The burden of prenatal exposure to alcohol: revised measurement of cost.
Stade B; Ali A; Bennett D; Campbell D; Johnston M; Lens C; Tran S; Koren G
Can J Clin Pharmacol; 2009; 16(1):e91-102. PubMed ID: 19168935
[TBL] [Abstract][Full Text] [Related]
27. The Economic Burden of End-Organ Damage Among Medicaid Patients with Sickle Cell Disease in the United States: A Population-Based Longitudinal Claims Study.
Campbell A; Cong Z; Agodoa I; Song X; Martinez DJ; Black D; Lew CR; Varker H; Chan C; Lanzkron S
J Manag Care Spec Pharm; 2020 Sep; 26(9):1121-1129. PubMed ID: 32597290
[TBL] [Abstract][Full Text] [Related]
28. Lapses in Medicaid coverage: impact on cost and utilization among individuals with diabetes enrolled in Medicaid.
Hall AG; Harman JS; Zhang J
Med Care; 2008 Dec; 46(12):1219-25. PubMed ID: 19300311
[TBL] [Abstract][Full Text] [Related]
29. Health care expenditures among Medicaid enrolled children with and without orofacial clefts in North Carolina, 1995-2002.
Cassell CH; Meyer R; Daniels J
Birth Defects Res A Clin Mol Teratol; 2008 Nov; 82(11):785-94. PubMed ID: 18985685
[TBL] [Abstract][Full Text] [Related]
30. Sickle cell hospital unit: a disease-specific model.
Adams-Graves P; Ostric EJ; Martin M; Richardson P; Lewis JB
J Healthc Manag; 2008; 53(5):305-15; discussion 316-7. PubMed ID: 18856136
[TBL] [Abstract][Full Text] [Related]
31. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
[TBL] [Abstract][Full Text] [Related]
32. High costs of influenza: Direct medical costs of influenza disease in young children.
Fairbrother G; Cassedy A; Ortega-Sanchez IR; Szilagyi PG; Edwards KM; Molinari NA; Donauer S; Henderson D; Ambrose S; Kent D; Poehling K; Weinberg GA; Griffin MR; Hall CB; Finelli L; Bridges C; Staat MA;
Vaccine; 2010 Jul; 28(31):4913-9. PubMed ID: 20576536
[TBL] [Abstract][Full Text] [Related]
33. Young adults with SCD in US children's hospitals: are they different from adolescents?
Dickerson AK; Klima J; Rhodes MM; O'Brien SH
Pediatr Blood Cancer; 2012 May; 58(5):741-5. PubMed ID: 21796763
[TBL] [Abstract][Full Text] [Related]
34. Direct medical cost of influenza-related hospitalizations in children.
Keren R; Zaoutis TE; Saddlemire S; Luan XQ; Coffin SE
Pediatrics; 2006 Nov; 118(5):e1321-7. PubMed ID: 17079533
[TBL] [Abstract][Full Text] [Related]
35. Use of a diagnosis-based risk adjustment model to estimate costs of indigent care in a community at Medicaid reimbursement rates.
Leslie RC; Shepherd MD; Simmons SC
J Med Econ; 2008; 11(4):585-600. PubMed ID: 19450069
[TBL] [Abstract][Full Text] [Related]
36. Preoperative screening for sickle cell disease in children: clinical implications.
Crawford MW; Galton S; Abdelhaleem M
Can J Anaesth; 2005 Dec; 52(10):1058-63. PubMed ID: 16326676
[TBL] [Abstract][Full Text] [Related]
37. Incidence, characteristics, and economic burden of rotavirus gastroenteritis associated with hospitalization of israeli children <5 years of age, 2007-2008.
Muhsen K; Shulman L; Rubinstein U; Kasem E; Kremer A; Goren S; Zilberstein I; Chodick G; Ephros M; Cohen D;
J Infect Dis; 2009 Nov; 200 Suppl 1():S254-63. PubMed ID: 19817606
[TBL] [Abstract][Full Text] [Related]
38. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening.
Peters M; Fijnvandraat K; van den Tweel XW; Garre FG; Giordano PC; van Wouwe JP; Pereira RR; Verkerk PH
Arch Dis Child; 2010 Oct; 95(10):822-5. PubMed ID: 20576657
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary function correlates with body composition in Nigerian children and young adults with sickle cell disease.
VanderJagt DJ; Trujillo MR; Jalo I; Bode-Thomas F; Glew RH; Agaba P
J Trop Pediatr; 2008 Apr; 54(2):87-93. PubMed ID: 17901067
[TBL] [Abstract][Full Text] [Related]
40. Health care costs and utilization rates for children with pervasive developmental disorders in North Dakota from 1998 to 2004: impact on Medicaid.
Peng CZ; Hatlestad P; Klug MG; Kerbeshian J; Burd L
J Child Neurol; 2009 Feb; 24(2):140-7. PubMed ID: 19182149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
